OPKO Health, Inc. Cash Provided by (Used in) Operating Activities, Discontinued Operations
OPKO Health, Inc. (OPK) reported Cash Provided by (Used in) Operating Activities, Discontinued Operations of $0 for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations · last filed 2014-03-03
- OPKO Health, Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2013-12-31 was $0.00.
- OPKO Health, Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2013-09-30 was $0.00, a 100.00% decline year-over-year.
- OPKO Health, Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2012-12-31 was -$7.00K.
- OPKO Health, Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2012-09-30 was $96.00K.
- OPKO Health, Inc. cash provided by (used in) operating activities, discontinued operations for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- OPKO Health, Inc. cash provided by (used in) operating activities, discontinued operations for fiscal 2012 was $7.00K.
- OPKO Health, Inc. cash provided by (used in) operating activities, discontinued operations for fiscal 2011 was -$4.56M.
- OPKO Health, Inc. cash provided by (used in) operating activities, discontinued operations for fiscal 2010 was -$1.55M.
| Period end | Cash Provided by (Used in) Operating Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 9 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 12 month |
|---|---|---|---|---|
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $0.00 derived: sum of 2 quarters · filed 2014-03-03 | $0.00 10-K · filed 2014-03-03 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $0.00 10-Q · filed 2013-11-12 | ||
| 2013-06-30 | $0.00 10-Q · filed 2013-08-09 | |||
| 2012-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $89.00K derived: sum of 2 quarters · filed 2014-03-03 | -$68.00K derived: sum of 3 quarters · filed 2014-03-03 | $7.00K 10-K · filed 2014-03-03 |
| 2012-09-30 | $96.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$61.00K derived: sum of 2 quarters · filed 2013-11-12 | $14.00K 10-Q · filed 2013-11-12 | -$267.00K derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | -$157.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$82.00K 10-Q · filed 2013-08-09 | -$363.00K derived: sum of 3 quarters · filed 2014-03-03 | -$1.95M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | $75.00K 10-Q · filed 2013-05-10 | -$206.00K derived: sum of 2 quarters · filed 2014-03-03 | -$1.79M derived: sum of 3 quarters · filed 2014-03-03 | -$2.90M derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | -$281.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$1.87M derived: sum of 2 quarters · filed 2014-03-03 | -$2.98M derived: sum of 3 quarters · filed 2014-03-03 | -$4.56M 10-K · filed 2014-03-03 |
| 2011-09-30 | -$1.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$2.69M derived: sum of 2 quarters · filed 2012-11-09 | -$4.28M 10-Q · filed 2012-11-09 | -$4.91M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | -$1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$2.69M 10-Q · filed 2012-08-09 | -$3.32M derived: sum of 3 quarters · filed 2013-03-18 | |
| 2011-03-31 | -$1.59M 10-Q · filed 2012-05-10 | -$2.21M derived: sum of 2 quarters · filed 2013-03-18 | ||
| 2010-12-31 | -$626.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$1.55M 10-K · filed 2013-03-18 | ||
| 2010-09-30 | -$927.00K 10-Q · filed 2011-11-09 | |||
| 2009-12-31 | -$4.07M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |